Nihon Kohden Singapore, a leading global medical device manufacturer from Japan, together with its local partner Hemas ...

Beacon Biosignals, a leader in AI-driven neurophysiology and precision drug development, today announced a collaboration with Harmony Biosciences (Nasdaq: HRMY), a pharmaceutical company dedicated to ...

CeriBell gains FDA clearance for its continuous delirium monitoring solution, boosting its AI-driven EEG platform and expanding its role in critical care.

Baystreet.ca News Commentary – The healthcare AI market reached $21.66 billion in 2025 and analysts now project growth to $110.61 billion by 2030[1] as artificial intelligence ...

The FDA has granted 510(k) clearance to a Bay Area medical technology firm for its proprietary delirium monitoring solution, ...

Datasea (Nasdaq:DTSS) announced progress on R&D efforts related to its brain-computer interface (BCI) technologies.

A patient controls a robotic dog during the BCI clinical trail. Photo: Courtesy of the CEBSIT. The Global Times learned on ...

A research paper by scientists at the Beijing Institute of Technology proposed a brain–machine hybrid intelligent system for ...

A new study from researchers at MIT has raised questions about the potential impact of GenAI tools on critical thinking and ...

A lot of brain development happens early in life, but researchers don't have a strong understanding of how a baby's brain ...

ChatGPT users showed the greatest drop, with more than a 50% reduction in several cognitive regions. Over repeated sessions, ...

The breakthrough is the result of a collaboration between Dentsu Lab and long-term client partner NTT, Inc., one of the world ...